EPO Patents = 3

Forward Citations = 1

Loading Chart...

7 inventors (with patents filed for the assignee):

Jean-Louis Henri Dasseux (8 out of 59 patents)

Rose Ackermann (2 out of 7 patents)

Daniela Carmen Oniciu (2 out of 13 patents)

4. Ronald Barbaras (2 out of 7 patents)

5. Laura Calabresi (2 out of 2 patents)

6. Cyrille Tupin (2 out of 2 patents)

7. Constance Peyrottes (2 out of 2 patents)

8 patents: Sort by Forward Citations

1. 12364705 - CER-001 therapy for treating kidney disease (2025-07-22),

2. 12297168 - Compounds useful for treating liver diseases (2025-05-13),

3. 12220462 - Complexes for delivery of cyclic dinucleotides (2025-02-11),

4. 11998587 - Lipoprotein complexes and manufacturing and uses thereof (2024-06-04),

5. 11969456 - Lipoprotein complexes and manufacturing and uses thereof (2024-04-30),

6. 11801282 - Charged lipoprotein complexes and their uses (2023-10-31),

7. 11752163 - CER-001 therapy for treating kidney disease (2023-09-12),

8. 11634387 - Compounds useful for treating liver diseases (2023-04-25),

Company Overview

Abionyx Pharma Sa is a biopharmaceutical company specializing in the development of innovative treatments for rare and severe diseases. Their focus lies in rare neurological and autoimmune disorders. With a strong commitment to research and development, Abionyx Pharma Sa aims to improve the lives of patients through cutting-edge therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

8 Patents

#2 in Balma

#2,022 in France

Balma, France

Abionyx Pharma Sa

Forward Citations = 1

7 inventors:

Jean-Louis Henri Dasseux (8 out of 59 patents)

Rose Ackermann (2 out of 7 patents)

Daniela Carmen Oniciu (2 out of 13 patents)

4. Ronald Barbaras (2 out of 7 patents)

5. Laura Calabresi (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Abionyx Pharma Sa. Retrieved from https://idiyas.com/company/abionyx-pharma-sa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]